Enhabit, Inc. (NYSE: EHAB) Downgraded by UBS Amid Acquisition by Kinderhook Industries

Core Viewpoint - Enhabit, Inc. is undergoing a significant acquisition by Kinderhook Industries, valued at approximately $1.1 billion, which is expected to enhance its market position and benefit stakeholders [2][4]. Company Overview - Enhabit, Inc. is a leading provider of home health and hospice services in the United States, known for its comprehensive care solutions [1]. Acquisition Details - UBS downgraded Enhabit’s stock rating to Neutral from Hold as the company enters a definitive acquisition agreement with Kinderhook Industries [2][5]. - Stockholders of Enhabit will receive $13.80 per share in cash as part of the acquisition agreement, which includes a premium over the current stock price of $13.60 [3][5]. - The acquisition is an all-cash transaction valued at approximately $1.1 billion [2]. Stock Performance - Enhabit’s stock has increased by 22.63%, reflecting investor optimism regarding the acquisition, with a rise of $2.51 [3][5]. - The stock price has fluctuated between $13.55 and $13.64, with $13.64 being the highest price over the past year [3]. - The market capitalization of Enhabit is approximately $689.4 million, with a trading volume of 12.6 million shares [4].